Publications by authors named "Barbara Metch"

Claim this Profile
C
Chemoprophylaxis Vaccination: Phase I Study to Explore Stage-specific Immunity to Plasmodium falciparum in US Adults.
Sara A Healy, Sean C Murphy, Jen C C Hume, Lisa Shelton, Steve Kuntz, Barbara Metch

Clin Infect Dis· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Demographic Analysis of Racial/Ethnic Minority Enrollment Into HVTN Preventive Early Phase HIV Vaccine Clinical Trials Conducted in the United States, 2002-2016.
Katherine Foy Huamani, Barbara Metch, Gail Broder, Michele Andrasik

Public Health Rep· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substance use patterns of HVTN phase I clinical trial participants: Enrollment, risk reduction counseling and retention.
Arame Thiam-Diouf, Barbara Metch, Cameron Sharpe, Robel Mulugeta, Michele Peake Andrasik

Vaccine· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continued Follow-Up of Phambili Phase 2b Randomized HIV-1 Vaccine Trial Participants Supports Increased HIV-1 Acquisition among Vaccinated Men.
Zoe Moodie, Barbara Metch, Linda-Gail Bekker, Gavin Churchyard, Maphoshane Nchabeleng

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials.
Yunda Huang, Dean Follmann, Martha Nason, Lily Zhang, Ying Huang, Barbara Metch

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of HIV vaccine candidates for concurrent testing in an efficacy trial.
Ying Huang, Carlos DiazGranados, Holly Janes, Yunda Huang, Allan C deCamp, Barbara Metch

Curr Opin Virol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of Identifying a Female Sex Worker Cohort at High Risk of HIV Infection in the Caribbean for HIV Vaccine Efficacy Trials: Longitudinal Results of HVTN 907.
Marie M Deschamps, Barbara Metch, Cecilia A Morgan, Carmen D Zorilla, Yeycy Donastorg

J Acquir Immune Defic Syndr· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study.
Glenda E Gray, Zoe Moodie, Barbara Metch, Peter B Gilbert, Linda-Gail Bekker

Lancet Infect Dis· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery.
Spyros A Kalams, Scott D Parker, Marnie Elizaga, Barbara Metch, Srilatha Edupuganti

J Infect Dis· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.
Richard M Novak, Barbara Metch, Susan Buchbinder, Robinson Cabello, Yeycy Donastorg

AIDS· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of identifying a cohort of US women at high risk for HIV infection for HIV vaccine efficacy trials: longitudinal results of HVTN 906.
Beryl A Koblin, Barbara Metch, Richard M Novak, Cecilia Morgan, Debbie Lucy

J Acquir Immune Defic Syndr· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recruitment of urban US women at risk for HIV infection and willingness to participate in future HIV vaccine trials.
Barbara Metch, Ian Frank, Richard Novak, Edith Swann, David Metzger

AIDS Behav· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses.
Stephen R Walsh, Michael S Seaman, Lauren E Grandpre, Cherie Charbonneau, Katherine E Yanosick, Barbara Metch

Vaccine· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults.
Spyros A Kalams, Scott Parker, Xia Jin, Marnie Elizaga, Barbara Metch

PLoS One· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.
Glenda E Gray, Mary Allen, Zoe Moodie, Gavin Churchyard, Linda-Gail Bekker, Barbara Metch

Lancet Infect Dis· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects.
Michael C Keefer, Sharon E Frey, Marnie Elizaga, Barbara Metch, Stephen C De Rosa

Vaccine· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients.
Cristine J Cooper, Barbara Metch, Joan Dragavon, Robert W Coombs, Lindsey R Baden

JAMA· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a CTL multiepitope peptide vaccine for HIV with or without GM-CSF in a phase I trial.
Paul Spearman, Spyros Kalams, Marnie Elizaga, Barbara Metch, Ya-Lin Chiu

Vaccine· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HVTN protocol 903 vaccine preparedness study: lessons learned in preparation for HIV vaccine efficacy trials.
Gaston Djomand, Barbara Metch, Carmen D Zorrilla, Yeycy Donastorg, Martin Casapia

J Acquir Immune Defic Syndr· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120.
Farley Cleghorn, Jean W Pape, Mauro Schechter, Courtenay Bartholomew, Jorge Sanchez, Barbara J Metch

J Acquir Immune Defic Syndr· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines.
David C Montefiori, Barbara Metch, M Juliana McElrath, Steve Self, Kent J Weinhold

J Infect Dis· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation.
Susan P Buchbinder, Barbara Metch, Sarah E Holte, Susan Scheer, Anne Coletti

J Acquir Immune Defic Syndr· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis